Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2005 1
2008 1
2009 2
2010 3
2011 1
2014 3
2015 1
2016 2
2017 2
2018 4
2019 3
2020 5
2021 1
2022 4
2023 4
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Cahn P, et al. Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Lancet. 2019. PMID: 30420123 Clinical Trial.
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.
Nasreddine R, Florence E, Yombi JC, Henrard S, Darcis G, Van Praet J, Vandekerckhove L, Allard SD, Demeester R, Messiaen P, Ausselet N, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH). Nasreddine R, et al. Among authors: demeester r. HIV Med. 2023 Aug;24(8):914-924. doi: 10.1111/hiv.13493. Epub 2023 Apr 10. HIV Med. 2023. PMID: 37038245 Free article.
A public health value-based healthcare paradigm for HIV.
Vermeersch S, Demeester RP, Ausselet N, Callens S, De Munter P, Florence E, Goffard JC, Henrard S, Lacor P, Messiaen P, Libois A, Seyler L, Uurlings F, Vandecasteele SJ, Van Wijngaerden E, Yombi JC, Annemans L, De Wit S. Vermeersch S, et al. Among authors: demeester rp. BMC Health Serv Res. 2022 Jan 2;22(1):13. doi: 10.1186/s12913-021-07371-7. BMC Health Serv Res. 2022. PMID: 34974833 Free PMC article.
Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.
Libois A, Florence E, Derdelinckx I, Yombi JC, Henrard S, Uurlings F, Vandecasteele S, Allard SD, Demeester R, Van Wanzeele F, Ausselet N, De Wit S. Libois A, et al. Among authors: demeester r. Acta Clin Belg. 2018 Aug;73(4):275-280. doi: 10.1080/17843286.2018.1428506. Epub 2018 Feb 12. Acta Clin Belg. 2018. PMID: 29429390
Impact of collaborative physician-pharmacist stewardship strategies on prophylactic antibiotic practices: a quasi-experimental study.
Pardo A, Ntabaza V, Rivolta M, Goulard A, Sténuit S, Demeester R, Milas S, Duez P, Patris S, Joris M, Dony P, Cherifi S. Pardo A, et al. Among authors: demeester r. Antimicrob Resist Infect Control. 2022 Jul 26;11(1):100. doi: 10.1186/s13756-022-01138-3. Antimicrob Resist Infect Control. 2022. PMID: 35883189 Free PMC article.
A traveler with neurobrucellosis.
Van den Enden E, Vlieghe E, Demeester R, Ieven G, Jansens H, Van den Hauwe L. Van den Enden E, et al. Among authors: demeester r. Travel Med Infect Dis. 2009 Jul;7(4):215-8. doi: 10.1016/j.tmaid.2009.05.004. Epub 2009 Jun 13. Travel Med Infect Dis. 2009. PMID: 19717103
Dynamics of Weight Change After Initiation of Contemporaneous Antiretroviral Therapy in Treatment-Naive HIV-1 Infected Patients: Results From the Belgian HIV Cohort 2015-2021.
Van Praet JT, Serrien B, Ausselet N, Darcis G, Demeester R, De Munter P, De Scheerder MA, Goffard JC, Libois A, Messiaen P, Yombi JC, Van Beckhoven D; Belgian HIV Cohort Study Group. Van Praet JT, et al. Among authors: demeester r. J Acquir Immune Defic Syndr. 2023 Jun 1;93(2):e4-e5. doi: 10.1097/QAI.0000000000003175. J Acquir Immune Defic Syndr. 2023. PMID: 36787727 No abstract available.
37 results